Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

Patients with type 2 diabetes mellitus (T2DM) are characterized by an elevated glycemic index and are at a higher risk for complications such as cardiovascular disease, nephropathy, retinopathy and peripheral ...

Source: BMC Clinical Pharmacology - June 13, 2021 Category: Drugs & Pharmacology Authors: Robert Dobbins, Elizabeth K. Hussey, Robin O ’Connor-Semmes, Susan Andrews, Wenli Tao, William O. Wilkison, Bentley Cheatham, Katare Sagar and Barkate Hanmant Tags: Research article Source Type: research